CBL and chronic myelomonocytic leukemia: The mechanism by which homozygosity for CBL UbLOF variants underlies autoinflammation probably also operates in the autoinflammatory disease observed in patients with CMML (54) and potentially also other dysplastic or proliferative myeloid conditions driven by somatic variants of CBL or other RAS-activating lesions.